Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 6.32M | $49.0M | 8.14% | +356.5K | 2026-06-30 |
| Deep Track Capital, LP | 6.27M | $49.0M | 8.08% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.14M | $24.0M | 4.04% | +5.4K | 2026-06-30 |
| STATE STREET CORP | 2.32M | $18.0M | 2.98% | +125.0K | 2026-06-30 |
| ROYCE & ASSOCIATES LP | 2.18M | $17.0M | 2.80% | +288.8K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.95M | $15.0M | 2.51% | +130.1K | 2026-06-30 |
| UBS Group AG | 1.88M | $14.0M | 2.42% | +339.7K | 2026-06-30 |
| OBERWEIS ASSET MANAGEMENT INC/ | 1.32M | $10.0M | 1.70% | +112.8K | 2026-06-30 |
| Alyeska Investment Group, L.P. | 850.0K | $6.0M | 1.09% | -- | 2026-06-30 |
| MARSHALL WACE, LLP | 779.5K | $6.0M | 1.00% | +276.6K | 2026-06-30 |